Skip to Main Content

Author Details

David Cogdell
The University of Texas MD Anderson Cancer Center
1996
53
28
PMIDPaper TitleJournal TitlePublished Year
35811851Erratum: The origin of bladder cancer from mucosal field effects.iScience2022
32521509Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.iScience2020
33241214RNAi technology targeting the <i>FGFR3-TACC3</i> fusion breakpoint: an opportunity for precision medicine.Neurooncol Adv2020
32546765Assessment of Luminal and Basal Phenotypes in Bladder Cancer.Sci Rep2020
29428551Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.Eur Urol Focus2019
30784602Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis.Cell Rep2019
28985752Erratum to: MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis.J Hematol Oncol2017
28121485MIR506 induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway.Autophagy2017
25893308IGFBP2 potentiates nuclear EGFR-STAT3 signaling.Oncogene2016
31042547Accuracy of EasyChip HPV blot genotyping assay to detect high-risk HPV genotypes in SurePath Papanicolaou specimens.J Am Soc Cytopathol2016
29179445ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy.Oncotarget2016
27612592Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.EBioMedicine2016
27760566MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis.J Hematol Oncol2016
27125842Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies.J Pathol2016
26863633Examining plasma microRNA markers for colorectal cancer at different stages.Oncotarget2016
25737557Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.Proc Natl Acad Sci U S A2015
25995442Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.J Natl Cancer Inst2015
24677166MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.Oncol Rep2014
25300797Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma.J Hematol Oncol2014
24604117MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer.J Pathol2014
23007860Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma.J Pathol2013
23410973Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.Cancer Cell2013
23298836The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.J Clin Invest2013
22345562Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network.Proc Natl Acad Sci U S A2012
22967466[Expression of PRUNE2 mRNA and its positive correlation with non-coding RNA PCA3 in leiomyosarcoma].Zhonghua Zhong Liu Za Zhi2012
22245216Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer.Am J Pathol2012
22392969Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.Anesth Analg2012
22363599Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancer.PLoS One2012
21439246Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma.Chin J Cancer2011
21445232Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis.PLoS One2011
19896763Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma.Cancer Lett2010
20651304Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug.Mol Cell Proteomics2010
20218740Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma.Technol Cancer Res Treat2010
20218738APEX1 gene amplification and its protein overexpression in osteosarcoma: correlation with recurrence, metastasis, and survival.Technol Cancer Res Treat2010
17977987Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.J Clin Microbiol2008
18500260Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results.Mod Pathol2008
17192787Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma.Mod Pathol2007
17564428Analysis of signaling pathways in 90 cancer cell lines by protein lysate array.J Proteome Res2007
17360660Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas.Proc Natl Acad Sci U S A2007
16619307Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays.Proteomics2006
17002637Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis.Transfusion2006
17121430Dissection of signaling pathways in fourteen breast cancer cell lines using reverse-phase protein lysate microarray.Technol Cancer Res Treat2006
16963839Transcriptional activation of the carboxylesterase 2 gene by the p53 pathway.Cancer Biol Ther2006
16410724The SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration.Cancer Biol Ther2006
15647295Robust estimation of protein expression ratios with lysate microarray technology.Bioinformatics2005
15196312Improving signal intensities for genes with low-expression on oligonucleotide microarrays.BMC Genomics2004
12655024Data extraction from composite oligonucleotide microarrays.Nucleic Acids Res2003
11911655Monitoring of cDNA microarray with common primer target and hybridization specificity with selected targets.Biotechniques2002
11464521Sequence verification as quality-control step for production of cDNA microarrays.Biotechniques2001
11570499Comparative evaluation of laser-based microarray scanners.Biotechniques2001
  • 1 - 50 of 53

Recommended Authors

Xinmin Li
University of California los angeles
Career Start Year 2008
Number of shared co-authors 1
Wayne Yu
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Career Start Year 2005
Number of shared co-authors 0
Steffen Durinck
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 1
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 2
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 16
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 3
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 9
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 2
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 2
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Career Start Year 1996
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 4
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 1
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 3
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 1
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Phillip Buckhaults
University of South Carolina
Career Start Year 1993
Number of shared co-authors 0
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 7
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 1
Abdel G Elkahloun
National Human Genome Research Institute
Career Start Year 1990
Number of shared co-authors 3
Sean M Grimmond
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 4
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 0
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 4
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 0
Mark A Watson
Washington University School of Medicine
Career Start Year 1987
Number of shared co-authors 4
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 9

Collaborators

Wei Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers 35
Limei Hu
Aier Eye Hospital of Wuhan University
Co-authored papers 20
Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers 9
Ilya Shmulevich
Institute for Systems Biology
Co-authored papers 9
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 8
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Da Yang
Co-authored papers 7
Anil K Sood
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Colin P Dinney
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Bogdan Czerniak
University of Texas MD Anderson Cancer Center
Co-authored papers 6
Jolanta Bondaruk
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Jonathan C Trent
Sylvester Comprehensive Cancer Center, University of Miami
Co-authored papers 5
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Ioan Tabus
Tampere University of Technology
Co-authored papers 5
Jilong Yang
Tianjin Medical University Cancer Institute and Hospital
Co-authored papers 5
Matti Annala
University of British Columbia
Co-authored papers 5
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Co-authored papers 5
Yingmei Wang
Tianjin Medical University General Hospital
Co-authored papers 5
David J McConkey
Johns Hopkins School of Medicine
Co-authored papers 5
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers 4
Nathan D Price
Institute for Systems Biology
Co-authored papers 3
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Kenneth Aldape
National Cancer Institute
Co-authored papers 3
Raphael E Pollock
James Cancer Center, The Ohio State University
Co-authored papers 2
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 2
Chad V Pecot
University of North Carolina at Chapel Hill
Co-authored papers 2
Andrea Hategan
Co-authored papers 2
Nora M Navone
MD Anderson Cancer Center
Co-authored papers 2
James A Eddy
Benaroya Research Institute at Virginia Mason, Institute for Systems Biology, Sage Bionetworks, University of Illinois at Urbana-Champaign
Co-authored papers 2
Rajesha Rupaimoole
Harvard Medical School, Beth Israel Deaconess Medical Center
Co-authored papers 2
Release 1.2